FDA Investigator Leon L Crawley
Leon L Crawley has inspections in 3 countries as of 26 Apr 2024. Leon L Crawley has collaborated with a combined 1270 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
82
Last Inspection Date:
26 Apr 2024
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Canada,
Australia
Co-Investigator(s):
Abraham M Maekele,
Andrea H Norwood,
Ann B Borromeo,
Anna E Fain,
Anthony J Grace,
Ashley A Segura,
Audrey J Yarbrough,
Barbara D Wright,
Barbara T Carmichael,
Betsy C Galliher,
Brandy D Brown,
Brunilda Torres,
Byungja E Marciante,
Candice C Mandera,
Cheryl A Grandinetti,
Courtney A Gilbert,
Cynthia F Kleppinger, MD,
Dana M Klimavicz,
Dionne D Arline,
Donald J Mee,
Donna D Gallien, MPH,
Edwards,
Eileen J Bannerman,
Figarole,
Gene R Gunn,
Harry R Bringger, Jr,
Heather M Bullock,
Henry E Sanchez,
Hunt,
Ivy Z Bevill,
Jason D Abel,
Jawaid Hamid,
Joanne M Schlossin,
Joey C West,
John J Bernal,
Jonathan D Green,
Joseph F Owens,
Kassa Ayalew, MD,
Konsuela Y Glass,
Ladislav Kermet,
Lakisha N Morton,
LCDR Angelica M Chica,
LT Richard A Lyght,
Matthew B Thomaston,
Matthew R Coleman,
Matthew R Mcnew,
Megan R Anderson,
Melinda B Lewis,
Mendoza,
Michelle D Haamid,
Navid R Homayouni,
Nicole M Bell,
Ormond,
Patricia S Smith,
Patrick C Dooley,
Reynolds,
Ronnie E Jackson,
Samantha J Pinizzotto, D V M,
Sereen Gmorgan Murray,
Sheri L Stephenson,
Stacey F Rivette,
State Agency,
Stephanie E Hubbard,
Taylor G Barker,
Terri E Gibson,
Traci M Armand,
Tracy R Ball,
Travis M Beard,
Tyanna N Hadley,
Valerie J Grecek Trinh,
Vanessa E Coulter,
Virginia L Meeks,
William P Tonkins
Leon L Crawley's Documents
Publish Date | Document Type | Title |
---|---|---|
March, 2020 | FDA 483 | Adolfo Cueli MD - Form 483, 2020-03-05 |
June, 2017 | FDA 483 | James Foran - Form 483, 2017-06-12 |
September, 2020 | FDA 483 | Saranya Chumsri MD - Form 483, 2020-09-16 |
November, 2016 | FDA 483 | Charles Klodell, MD - Form 483, 2016-11-03 |
August, 2022 | FDA 483 | Ascension Sacred Heart Hospital IRB - Form 483, 2022-08-10 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more